Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
28.75
+0.50 (1.77%)
Sep 3, 2025, 4:36 PM ICT

Mega Lifesciences PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
1,8632,0121,9932,2421,9471,393
Upgrade
Depreciation & Amortization
279.19277.74279.98265.18268.86250.98
Upgrade
Other Amortization
5.695.695.896.835.575.35
Upgrade
Loss (Gain) From Sale of Assets
-5.4-2.65-2.87-2.08-3.510.51
Upgrade
Asset Writedown & Restructuring Costs
-0.92-0.59-0.548.5928.02-
Upgrade
Loss (Gain) on Equity Investments
0.31-0.15-0.07-0.181.5145.52
Upgrade
Provision & Write-off of Bad Debts
1.133.6812.175.833.092.18
Upgrade
Other Operating Activities
163.56251.64238.7270.439.8127.31
Upgrade
Change in Accounts Receivable
-93.8231.3-322.23-631.4718.0268.51
Upgrade
Change in Inventory
222.7447.19569.37-576.69-273.63-602.17
Upgrade
Change in Accounts Payable
-536.31-278.66-885.27364.68375.6848.44
Upgrade
Change in Other Net Operating Assets
-243.1-546.2838.65243.99316.59290.15
Upgrade
Operating Cash Flow
1,6562,4011,9261,9972,7271,629
Upgrade
Operating Cash Flow Growth
-37.92%24.65%-3.51%-26.78%67.35%8.98%
Upgrade
Capital Expenditures
-518.6-247.53-274.65-304.6-151.4-234.43
Upgrade
Sale of Property, Plant & Equipment
4.7817.724.532.866.474.04
Upgrade
Cash Acquisitions
----9.25--410.56
Upgrade
Sale (Purchase) of Intangibles
-8.93-9.76-18.93-8.14-8.38-20.64
Upgrade
Investment in Securities
-171.93178.14-20.11-1.75-122.570.62
Upgrade
Other Investing Activities
67.4962.8759.1440.0711.1910.68
Upgrade
Investing Cash Flow
-627.181.45-250.01-280.83-264.68-650.28
Upgrade
Short-Term Debt Issued
-215.37-65.2--
Upgrade
Total Debt Issued
285.05215.37-65.2--
Upgrade
Short-Term Debt Repaid
---148.66--309.49-432.03
Upgrade
Long-Term Debt Repaid
--60.16-88.6-58.1-53.52-55.54
Upgrade
Total Debt Repaid
-60.59-60.16-237.26-58.1-363.01-487.57
Upgrade
Net Debt Issued (Repaid)
224.46155.21-237.267.1-363.01-487.57
Upgrade
Common Dividends Paid
-1,394-1,395-1,439-1,406-922.94-670.19
Upgrade
Other Financing Activities
-39.61-38.04-31.75-34.76-27.93-64.63
Upgrade
Financing Cash Flow
-1,210-1,277-1,708-1,433-1,314-1,222
Upgrade
Foreign Exchange Rate Adjustments
-147.83-19.42-64.92-26.7642.981.77
Upgrade
Net Cash Flow
-328.81,106-96.74255.771,191-241.47
Upgrade
Free Cash Flow
1,1372,1541,6521,6922,5751,395
Upgrade
Free Cash Flow Growth
-52.96%30.39%-2.38%-34.30%84.62%44.32%
Upgrade
Free Cash Flow Margin
7.95%14.00%10.51%10.76%18.17%11.06%
Upgrade
Free Cash Flow Per Share
1.302.471.901.942.951.60
Upgrade
Cash Interest Paid
39.6138.0431.7529.8527.9364.63
Upgrade
Cash Income Tax Paid
380.87362.3423.09389.5362.76227.43
Upgrade
Levered Free Cash Flow
1,2282,2891,4131,2091,989864.17
Upgrade
Unlevered Free Cash Flow
1,2572,3141,4331,2272,006909.34
Upgrade
Change in Working Capital
-650.51-146.45-599.47-599.49436.66-195.08
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.